SERB is a European specialty pharmaceutical group focused on prescription medicines which address rare and life-threatening diseases.
Following strategic acquisitions and targeted developments, SERB has succeeded in establishing a consistent drugs portfolio focused on niche specialty pharmaceuticals to ensure continuous availability of life-saving medicines and answer unmet medical needs. Their commitment is to continue to offer essential drugs meeting Public Health needs.
SERB’s Key Focuses:
- Emergency Care
SERB is established in Belgium (Headquarter), France, the United Kingdom and Luxembourg, and is present in over 60 countries through a large network of experienced distributors.
For more information about SERB, click here.